Recent Finacing
Recent Raise
Jecure develops small-molecule therapies for NASH and liver fibrosis using a UCSD-derived platform of siRNA murine fibrosis models, knock‑in in vitro screening, and NASH in vivo models targeting inflammasome pathways.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor